FR2401935B1 - - Google Patents
Info
- Publication number
- FR2401935B1 FR2401935B1 FR7824922A FR7824922A FR2401935B1 FR 2401935 B1 FR2401935 B1 FR 2401935B1 FR 7824922 A FR7824922 A FR 7824922A FR 7824922 A FR7824922 A FR 7824922A FR 2401935 B1 FR2401935 B1 FR 2401935B1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82838577A | 1977-08-29 | 1977-08-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2401935A1 FR2401935A1 (fr) | 1979-03-30 |
| FR2401935B1 true FR2401935B1 (it) | 1981-07-10 |
Family
ID=25251653
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7824922A Granted FR2401935A1 (fr) | 1977-08-29 | 1978-08-29 | Nouveaux 25-alkylcholesterols utiles notamment comme hypocholesterolemiants et leur procede de preparation |
Country Status (9)
| Country | Link |
|---|---|
| JP (1) | JPS5448751A (it) |
| AU (1) | AU520334B2 (it) |
| CA (1) | CA1113086A (it) |
| CH (1) | CH643566A5 (it) |
| DE (1) | DE2837414A1 (it) |
| ES (1) | ES472877A1 (it) |
| FR (1) | FR2401935A1 (it) |
| GB (1) | GB2009180B (it) |
| IT (1) | IT1106121B (it) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4225525A (en) * | 1979-02-08 | 1980-09-30 | Hoffmann-La Roche Inc. | Vitamin D3 metabolite derivatives |
| US4230626A (en) * | 1979-07-30 | 1980-10-28 | G. D. Searle & Co. | 25-Halocholest-5-ene-3β,22-diols and esters thereof |
| US4329295A (en) * | 1981-06-29 | 1982-05-11 | G. D. Searle & Co. | 24-Cyclopropylcholene-3β, 22-diols and esters thereof |
| US4348328A (en) * | 1981-11-09 | 1982-09-07 | G.D. Searle & Co. | 25-Substituted-5α-cholestane-3β,22S-diol |
| IL105050A0 (en) * | 1992-03-27 | 1993-07-08 | Lilly Co Eli | Steroid derivatives |
| DK1163258T3 (da) * | 1999-03-09 | 2003-03-31 | Akzo Nobel Nv | Derivater af 22R-hydroxycholesta-8, 14-dien til inhiberingen af meiosis |
| CN1498222A (zh) * | 2001-02-08 | 2004-05-19 | 芝加哥大学 | 类固醇衍生物 |
| US7078396B2 (en) | 2001-05-03 | 2006-07-18 | Arch Development Corporation | Method of treating disorder related to high cholesterol concentration |
| EP2459581A4 (en) | 2009-07-29 | 2012-12-26 | Univ Chicago | LIVER X RECEPTOR AGONISTS |
-
1978
- 1978-08-28 ES ES472877A patent/ES472877A1/es not_active Expired
- 1978-08-28 JP JP10480878A patent/JPS5448751A/ja active Granted
- 1978-08-28 CA CA310,200A patent/CA1113086A/en not_active Expired
- 1978-08-28 CH CH906378A patent/CH643566A5/de not_active IP Right Cessation
- 1978-08-28 DE DE19782837414 patent/DE2837414A1/de active Granted
- 1978-08-28 AU AU39318/78A patent/AU520334B2/en not_active Expired
- 1978-08-28 IT IT50879/78A patent/IT1106121B/it active
- 1978-08-29 GB GB7834881A patent/GB2009180B/en not_active Expired
- 1978-08-29 FR FR7824922A patent/FR2401935A1/fr active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| CA1113086A (en) | 1981-11-24 |
| GB2009180B (en) | 1982-05-26 |
| DE2837414A1 (de) | 1979-03-08 |
| CH643566A5 (de) | 1984-06-15 |
| ES472877A1 (es) | 1979-02-16 |
| FR2401935A1 (fr) | 1979-03-30 |
| JPS5448751A (en) | 1979-04-17 |
| IT1106121B (it) | 1985-11-11 |
| AU3931878A (en) | 1980-03-06 |
| AU520334B2 (en) | 1982-01-28 |
| GB2009180A (en) | 1979-06-13 |
| IT7850879A0 (it) | 1978-08-28 |
| DE2837414C2 (it) | 1987-09-03 |
| JPS6259720B2 (it) | 1987-12-12 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |